List Results  
  Refine Search  
  Results by Topic  
  Results on Map  
  Search Details  
Found 10 studies with search of:   "Talaporfin"
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Active, not recruiting A Phase 3 Study of Talaporfin Sodium and Interstitial Light Emitting Diodes Treating Hepatocellular Carcinoma (HCC)
Conditions: Carcinoma, Hepatocellular;   Liver Neoplasms
Interventions: Drug: Talaporfin sodium;   Device: Interstitial Light Emitting Diodes;   Procedure: Percutaneous placement of device in the liver;   Procedure: Standard Care
2 Recruiting Phase 1 Study of the Litx™ BPH System in Patients With Lower Urinary Tract Symptoms (LUTS) Due to Benign Prostatic Hyperplasia (BPH)
Conditions: Benign Prostatic Hyperplasia;   Lower Urinary Tract Symptoms
Interventions: Drug: Talaporfin sodium;   Procedure: Placement of device in prostate urethra;   Device: Transurethral illumination with light emitting diodes (Litx™ BPH Device)
3 Completed Photodynamic Therapy With Talaporfin Sodium (LS11) in Treating Patients With Refractory Colorectal Liver Metastases
Conditions: Liver Metastasis;   Colorectal Neoplasms;   Liver Neoplasms;   Neoplasm Metastasis
Interventions: Drug: Talaporfin sodium (LS11);   Device: LED-based light infusion device;   Device: Light emitting diodes (LED);   Procedure: Photodynamic therapy;   Procedure: Phototherapy;   Procedure: Chemotherapy
4 Terminated Study of Talaporfin Sodium Photodynamic Therapy to Treat Advanced Age Related Macular Disease
Conditions: Macular Degeneration;   Choroidal Neovascularization
Intervention: Drug: Talaporfin Sodium (LS11) Photodynamic Therapy (PDT)
5 Completed Tumor Ablation With Talaporfin Sodium and Interstitial Light Emitting Diodes Treating Hepatocellular Carcinoma (HCC)
Conditions: Carcinoma, Hepatocellular;   Liver Neoplasms
Interventions: Procedure: Photodynamic therapy;   Drug: Talaporfin Sodium
6 Recruiting Phase I Clinical Study of the Safety of Photodynamic Therapy (PDT) Using LS11 in Children With Plexiform Neurofibromas
Condition: Neurofibroma
Intervention: Drug: LS11
7 Completed Phase IIa Safety and Light Dose-Escalation Study in Patients With Primary or Recurrent/High-Grade Glioma Using the Litx™ System to Confirm the Zone of Tumor Destruction During the Intraoperative Treatment of Glioma
Conditions: Glioma;   Glioblastoma Multiforme;   Anaplastic Astrocytoma
Interventions: Drug: LS11 (talaporfin sodium);   Device: Light source (interstitial light emitting diodes);   Procedure: Intraoperative placement of device in glioma
8 Recruiting Phase 3 Trial of Litx™ Plus Chemotherapy vs. Chemotherapy Only Treating Colorectal Cancer Patients With Recurrent Liver Metastases
Conditions: Liver Metastases;   Colorectal Neoplasms;   Neoplasm Metastasis;   Neoplasm Recurrence, Local
Interventions: Drug: Talaporfin sodium;   Procedure: Percutaneous placement of device in liver metastases;   Device: Interstitial light emitting diodes;   Drug: FOLFOX4 OR FOLFIRI regimen
9 Completed Photodynamic Therapy System for Patients With Refractory/Unresponsive Solid Tumors
Conditions: Liver Metastasis;   Pelvic Cancer;   Head and Neck Cancer;   Sarcoma;   Rectal Cancer;   Breast Cancer;   Colorectal Cancer;   Mouth Cancer
Interventions: Drug: LS 11(Taporfin Sodium);   Device: Lumaflex Light Delivery Catheter
10 Completed Study of the Litx™ System Combined With Chemotherapy in Patients With Colorectal Liver Metastases
Conditions: Liver Metastasis;   Colorectal Neoplasms;   Liver Neoplasms;   Neoplasm Metastasis
Interventions: Drug: Talaporfin sodium (LS11);   Device: LED-based light infusion device;   Device: Light emitting diodes (LED);   Procedure: Photodynamic therapy;   Procedure: Phototherapy;   Procedure: Chemotherapy

  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options